Literature DB >> 35138209

The predictive role of early CRP values for one-year mortality in the first 2 d after acute myocardial infarction.

Ahmad Alkouri1,2, Maria Cybularz1, Johannes Mierke1, Thomas Nowack1, Jonathan Biedermann1, Stefan Ulbrich1, Julia Fischer1, Felix M Heidrich1, Stefanie Jellinghaus1, Uwe Speiser1, Axel Linke1, Christian Pfluecke1,2.   

Abstract

BACKGROUND: An excessive inflammatory reaction after acute myocardial infarction (AMI) is known to be harmful. New anti-inflammatory therapies are required.
PURPOSE: This study assessed the predictive role of early CRP in patients with STEMI.
METHODS: A total of 1003 patients with STEMI were analysed. A total of 180 patients with proven infection were excluded. CRP after 12, 24 and 48 h after pain onset were evaluated.
RESULTS: Of 823 patients, 103 (12.5%) died within one year after AMI. The deceased patients showed higher CRP, even after already 12 h (6 vs. 13 mg/l, p < .001), 24 h (13 vs. 25 mg/l, p < .001) and after 48 h (40 vs. 92 mg/l, p < .001). A CRP of ≥8 mg/l, 12 h after AMI, was found in 45% and was independently associated with long-term mortality (OR: 2.7, p = .03), after 24 h: CRP ≥ 18 mg/l in 44% (OR: 2.5, p = .03), after 48 h: CRP ≥ 53 mg/l in 44% (OR 1.9, p = .03). Early CRP values correlated strongly with the later maximum value of CRP (p < .001).
CONCLUSIONS: Already early CRP values are accurate for risk-prediction following AMI. By identifying patients who are beginning to develop an excessive inflammatory response, it may be possible to identify those who benefit from anti-inflammatory therapies.

Entities:  

Keywords:  Acute myocardial infarction; C-reactive protein (CRP); heart failure: inflammation; remodelling

Mesh:

Substances:

Year:  2022        PMID: 35138209     DOI: 10.1080/1354750X.2022.2040591

Source DB:  PubMed          Journal:  Biomarkers        ISSN: 1354-750X            Impact factor:   2.658


  1 in total

Review 1.  Role of Inflammation in Cardiac Remodeling After Acute Myocardial Infarction.

Authors:  Francisco A Fonseca; Maria C Izar
Journal:  Front Physiol       Date:  2022-06-28       Impact factor: 4.755

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.